Medifast Inc (MED) stock
Close on Nov 12, 2026Market cap $143.81MP/E –Yield 0.00%
Medifast Inc saw revenue fall 30.3% to $299.57M over the twelve months to Sep 30, 2026. Free cash flow was -$3.87M, down 698.9% from a year earlier. At the latest close the market valued the company at $143.81M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $143.81M
- P/E ratio
- –
- Price to sales
- 0.48
- Price to book
- 0.80
- Dividend yield
- 0.00%
- Free cash flow yield
- -2.69%
Fundamentals
- Revenue
- $299.57M
- Net income
- -$40.85M
- EPS, diluted
- -$3.69
- Free cash flow
- -$3.87M
- Book value per share
- $16.12
- Diluted shares
- 11M
Trading
- Next earnings
- Feb 16, 2027 (estimated, during market hours)
- Previous close
- $13.13
- Open
- $13.02
- Day's range
- $12.81 – $13.16
- Volume
- 86,306
- Average volume (20 days)
- 137,409
- Beta (5 years)
- 0.71
- 52-week range
- $9.22 – $13.63
- RSI (14 days)
- 62.4
- Volatility (1 year)
- 53.7%
- Relative volume
- 0.58×
- WACC
- 8.4%
Market cap history
Month-end market cap since 2010, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | MED | S&P 500 | Difference | MED per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +10.7% | -2.7% | +13.4 pts | ||
| 3 months | +11.0% | -1.7% | +12.7 pts | ||
| Year to date | +20.4% | +11.9% | +8.5 pts | ||
| 1 year | +10.6% | +12.0% | −1.4 pts | ||
| 3 years | -80.3% | +78.2% | −158.5 pts | -41.8% | +21.2% |
| 5 years | -93.7% | +73.2% | −166.9 pts | -42.4% | +11.6% |
| 10 years | -57.5% | +309.6% | −367.2 pts | -8.2% | +15.1% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Medifast filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
- Update
- Update
- Results
About Medifast
Miscellaneous Food Preparations & Kindred Products
Medifast, Inc. provides coach-guided health, wellness, and lifestyle solutions centered on metabolic health and weight management. The company offers structured nutrition programs, such as its 5 & 1 and Optimal Weight plans, alongside proprietary food and nutritional product lines including OPTA VIA Fuelings, OPTA VIA ACTIVE, and OPTA VIA ASCEND. Its offerings combine scientifically formulated pre-portioned meal replacements, dietary supplements, habit-change blueprints, community support, and a companion mobile application. Medifast serves individual consumers seeking weight reduction, long-term weight maintenance, and metabolic wellness, including individuals who use weight-loss medications.
Company profile, executives and historyMedifast stock: common questions
What is Medifast's stock price?
MED closed at $12.86 on Nov 12, 2026, down 2.06% on the day. Over the past 52 weeks it traded between $9.22 and $13.63.
What is Medifast's market cap?
Medifast was worth $143.81M at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is MED's P/E ratio?
Medifast lost money over the twelve months to Sep 30, 2026 (diluted EPS -$3.69), so it has no meaningful P/E ratio.
How much revenue does Medifast make?
Medifast reported revenue of $299.57M for the twelve months to Sep 30, 2026, down 30.3% from a year earlier.
Does Medifast pay a dividend?
No. Medifast has not paid a cash dividend over the last twelve months.
When does Medifast report earnings next?
Medifast is expected to report Q4 FY2026 results on Feb 16, 2027, during market hours. The date is estimated from its past reporting pattern until the company confirms it.
How has MED stock performed over the past year?
Including dividends, MED returned +10.6% over the past year, against +12.0% for the S&P 500.
How many MED shares are sold short?
1M shares were sold short at the latest FINRA report, 13.23% of the float, or 8.2 days of average trading volume.
Who are Medifast's competitors?
Companies most similar to Medifast by business, industry and size include DDC, OMDA, WW, JVA, BYND.
See a number that looks wrong?